0001209191-18-022178.txt : 20180330 0001209191-18-022178.hdr.sgml : 20180330 20180330102051 ACCESSION NUMBER: 0001209191-18-022178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180328 FILED AS OF DATE: 20180330 DATE AS OF CHANGE: 20180330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bell Graeme CENTRAL INDEX KEY: 0001643757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 18725131 MAIL ADDRESS: STREET 1: 1324 WAVERLY ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-28 0 0001652130 Intellia Therapeutics, Inc. NTLA 0001643757 Bell Graeme C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139 0 1 0 0 EVP, Chief Financial Officer Common Stock 2018-03-28 4 M 0 8000 13.48 A 21400 D Stock Option (Right to buy) 13.48 2018-03-28 4 M 0 8000 0.00 D 2027-01-02 Common Stock 8000 202000 D On January 3, 2017, the Reporting Person was granted an option to purchase 210,000 common shares under the company's 2015 Amended and Restated Stock Option and Incentive Plan. The shares reported as being purchased in this Form 4 were fully vested and exercisable as of the transaction date. /s/Jose E. Rivera, Attorney-In-Fact 2018-03-30